Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 411

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Open access
Schmid, Yasmin, Enzler, Florian, Gasser, Peter, Grouzmann, Eric, Preller, Katrin H., Vollenweider, Franz X., Brenneisen, Rudolf, Müller, Felix, Borgwardt, Stefan, Liechti, Matthias E.·2015·Biological Psychiatry
DOI 10.1016/j.biopsych.2014.11.015
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2014.11.015

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 66

  1. Passie, 2008, The pharmacology of lysergic acid diethylamide: A review, CNS Neurosci Ther, 14, 295, 10.1111/j.1755-5949.2008.00059.x · DOI · Paper page
  2. Hofmann, 1979, How LSD originated, J Psychedelic Drugs, 11, 53, 10.1080/02791072.1979.10472092 · DOI
  3. Koelle, 1958, The pharmacology of mescaline and D-lysergic acid diethylamide (LSD), N Engl J Med, 258, 25, 10.1056/NEJM195801022580106 · DOI
  4. Bercel, 1956, Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction, AMA Arch Neurol Psychiatry, 75, 588, 10.1001/archneurpsyc.1956.02330240026003 · DOI
  5. Savage, 1973, Residential psychedelic (LSD) therapy for narcotic addict: A controlled study, Arch Gen Psychiatry, 28, 808, 10.1001/archpsyc.1973.01750360040005 · DOI · Paper page
  6. Sewell, 2006, Response of cluster headache to psilocybin and LSD, Neurology, 66, 1920, 10.1212/01.wnl.0000219761.05466.43 · DOI · Paper page
  7. Pahnke, 1969, LSD-assisted psychotherapy with terminal cancer patients, Curr Psychiatr Ther, 9, 144
  8. Stoll, 1947, Lysergsäureäthylamid, ein Phantastikum aus der Mutterkorngruppe, Schweiz Arch Neurol Psychiatr, 60, 279
  9. Rothlin, 1957, Lysergic acid diethylamide and related substances, Ann N Y Acad Sci, 66, 668, 10.1111/j.1749-6632.1957.tb40756.x · DOI
  10. Salvatore, 1956, Progression of effects of lysergic acid diethylamide (LSD), AMA Arch Neurol Psychiatry, 76, 50, 10.1001/archneurpsyc.1956.02330250052007 · DOI
  11. Hollister, 1962, Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures, Compr Psychiatry, 3, 235, 10.1016/S0010-440X(62)80024-8 · DOI
  12. Strassman, 1994, Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale, Arch Gen Psychiatry, 51, 98, 10.1001/archpsyc.1994.03950020022002 · DOI · Paper page
  13. Riba, 2002, Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively, Psychopharmacology, 165, 18, 10.1007/s00213-002-1237-5 · DOI
  14. Dos Santos, 2011, Autonomic, neuroendocrine, and immunological effects of ayahuasca: A comparative study with d-amphetamine, J Clin Psychopharmacol, 31, 717, 10.1097/JCP.0b013e31823607f6 · DOI
  15. Gouzoulis-Mayfrank, 2005, Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers, Pharmacopsychiatry, 38, 301, 10.1055/s-2005-916185 · DOI · Paper page
  16. Vollenweider, 1997, Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG), Eur Neuropsychopharmacol, 7, 9, 10.1016/S0924-977X(96)00039-9 · DOI · Paper page
  17. Vollenweider, 1997, Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis, Neuropsychopharmacology, 16, 357, 10.1016/S0893-133X(96)00246-1 · DOI · Paper page
  18. Kupferschmidt, 2014, High hopes, Science, 345, 18, 10.1126/science.345.6192.18 · DOI
  19. Hysek, 2014, Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone and in combination, Int J Neuropsychopharmacol, 17, 371, 10.1017/S1461145713001132 · DOI
  20. Martin, 1971, Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man, Clin Pharmacol Ther, 12, 245, 10.1002/cpt1971122part1245 · DOI · Paper page
  21. Hill, 1963, The Addiction Research Center Inventory: Standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, LSD-25, pyrahexyl and chlorpromazine, Psychopharmacologia, 4, 167, 10.1007/BF02584089 · DOI · Paper page
  22. Gouzoulis-Mayfrank, 1998, Hallucinogenic drug induced states resemble acute endogenous psychoses: Results of an empirical study, Eur Psychiatry, 13, 399, 10.1016/S0924-9338(99)80686-5 · DOI
  23. Geyer, 2008, Serotonin research: Contributions to understanding psychoses, Trends Pharmacol Sci, 29, 445, 10.1016/j.tips.2008.06.006 · DOI · Paper page
  24. Langs, 1968, Lysergic acid diethylamide (LSD-25) and schizophrenic reactions: A comparative study, J Nerv Ment Dis, 147, 163, 10.1097/00005053-196808000-00008 · DOI
  25. Braff, 1992, Gating and habituation of the startle reflex in schizophrenic patients, Arch Gen Psychiatry, 49, 206, 10.1001/archpsyc.1992.01820030038005 · DOI · Paper page
  26. Kumari, 2000, Prepulse inhibition of the startle response in men with schizophreni: Effects of age of onset of illness, symptoms, and medication, Arch Gen Psychiatry, 57, 609, 10.1001/archpsyc.57.6.609 · DOI · Paper page
  27. Ludewig, 2003, Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia, Biol Psychiatry, 54, 121, 10.1016/S0006-3223(02)01925-X · DOI · Paper page
  28. Quednow, 2008, Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia, Biol Psychiatry, 64, 766, 10.1016/j.biopsych.2008.04.019 · DOI
  29. Halberstadt, 2010, LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor, Psychopharmacology (Berl), 208, 179, 10.1007/s00213-009-1718-x · DOI
  30. Palenicek, 2010, Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition, Prog Neuropsychopharmacol Biol Psychiatry, 34, 588, 10.1016/j.pnpbp.2010.02.008 · DOI
  31. Ouagazzal, 2001, Effect of LSD on prepulse inhibition and spontaneous behavior in the rat: A pharmacological analysis and comparison between two rat strains, Neuropsychopharmacology, 25, 565, 10.1016/S0893-133X(01)00282-2 · DOI
  32. Sipes, 1997, DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum, Brain Res, 761, 97, 10.1016/S0006-8993(97)00316-8 · DOI
  33. Varty, 1995, Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs, Psychopharmacology (Berl), 122, 15, 10.1007/BF02246437 · DOI · Paper page
  34. Krebs-Thomson, 2006, The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats, Psychopharmacology (Berl), 189, 319, 10.1007/s00213-006-0566-1 · DOI
  35. Halberstadt, 2013, Serotonergic hallucinogens as translational models relevant to schizophrenia, Int J Neuropsychopharmacol, 16, 2165, 10.1017/S1461145713000722 · DOI
  36. Gouzoulis-Mayfrank, 1998, Methodological issues of human experimental research with hallucinogens, Pharmacopsychiatry, 31, 114, 10.1055/s-2007-979356 · DOI
  37. Farre, 2007, Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: Pharmacological effects and pharmacokinetics, J Pharmacol Exp Ther, 323, 954, 10.1124/jpet.107.129056 · DOI
  38. Janke, 1978, Die Eigenschaftswörterliste, Göttingen: Hogrefe
  39. Abraham, 1996, The psychopharmacology of hallucinogens, Neuropsychopharmacology, 14, 285, 10.1016/0893-133X(95)00136-2 · DOI
  40. Vollenweider, 1998, Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action, Neuroreport, 9, 3897, 10.1097/00001756-199812010-00024 · DOI · Paper page
  41. Shulgin, 1973, Mescaline: The chemistry and pharmacology of its analogs, Lloydia, 36, 46
  42. Hysek, 2012, Duloxetine inhibits effects of MDMA (“ecstasy”) in vitro and in humans in a randomized placebo-controlled laboratory study, PLoS One, 7, e36476, 10.1371/journal.pone.0036476 · DOI
  43. Braff, 1980, Acute and chronic LSD effects on rat startle: Data supporting an LSD rat model of schizophrenia, Biol Psychiatry, 15, 909
  44. Vollenweider, 2007, The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval, Neuropsychopharmacology, 32, 1876, 10.1038/sj.npp.1301324 · DOI · Paper page
  45. Gouzoulis-Mayfrank, 1998, Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans, Behav Pharmacol, 9, 561, 10.1097/00008877-199811000-00011 · DOI
  46. Quednow, 2012, Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers, Neuropsychopharmacology, 37, 630, 10.1038/npp.2011.228 · DOI · Paper page
  47. Heekeren, 2007, Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis, J Psychopharmacol, 21, 312, 10.1177/0269881107077734 · DOI
  48. Quednow, 2009, Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: A replication study, Biol Psychiatry, 66, 614, 10.1016/j.biopsych.2009.05.007 · DOI
  49. Kornetsky, 1957, Relation of physiological and psychological effects of lysergic acid diethylamide, AMA Arch Neurol Psychiatry, 77, 657, 10.1176/ajp.114.4.309 · DOI
  50. Dimascio, 1957, A study of the effects of L.S.D.: Physiologic and psychological changes and their interrelations, Am J Psychiatry, 114, 309, 10.1176/ajp.114.4.309 · DOI
  51. Sokoloff, 1957, The effects of D-lysergic acid diethylamide on cerebral circulation and over-all metabolism, Ann N Y Acad Sci, 66, 468, 10.1111/j.1749-6632.1957.tb40742.x · DOI
  52. Belleville, 1956, Studies on lysergic acid diethylamide (LSD-25): I. Effects in former morphine addicts and development of tolerance during chronic intoxication, AMA Arch Neurol Psychiatry, 76, 468, 10.1001/archneurpsyc.1956.02330290012002 · DOI
  53. Forrer, 1951, Experimental physiological studies with lysergic acid diethylamide (LSD-25), AMA Arch Neurol Psychiatry, 65, 581, 10.1001/archneurpsyc.1951.02320050038004 · DOI
  54. Hysek, 2011, The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (“ecstasy”) in humans, Clin Pharmacol Ther, 90, 246, 10.1038/clpt.2011.78 · DOI
  55. Horita, 1954, Pyretogenic effect of lysergic acid diethylamide, Science, 120, 1100, 10.1126/science.120.3131.1100 · doi:10.1126/science.120.3131.1100
  56. Klock, 1975, Coma, hyperthermia, and bleeding associated with massive LSD overdose, a report of eight cases, Clin Toxicol, 8, 191, 10.3109/15563657508988063 · DOI
  57. Isbell, 1959, Comparison of the reactions induced by psilocybin and LSD-25 in man, Psychopharmacologia, 1, 29, 10.1007/BF00408109 · DOI
  58. Gouzoulis-Mayfrank, 1999, Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers: Results of an experimental double blind placebo controlled study, Psychopharmacology, 142, 41, 10.1007/s002130050860 · DOI
  59. Strassman, 1994, Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects, Arch Gen Psychiatry, 51, 85, 10.1001/archpsyc.1994.03950020009001 · DOI · Paper page
  60. Watts, 1995, LSD and structural analogs: Pharmacological evaluation at D1 dopamine receptors, Psychopharmacology (Berl), 118, 401, 10.1007/BF02245940 · DOI
  61. Giacomelli, 1998, Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro, Life Sci, 63, 215, 10.1016/S0024-3205(98)00262-8 · DOI
  62. Meltzer, 1977, Lysergic acid diethylamide: Evidence for stimulation of pituitary dopamine receptors, Psychopharmacology (Berl), 54, 39, 10.1007/BF00426539 · DOI
  63. Sommers, 1994, Dexfenfluramine-induced prolactin release as an index of central synaptosomal 5-hydroxytryptamine during treatment with fluoxetine, Eur J Clin Pharmacol, 46, 441, 10.1007/BF00191908 · DOI
  64. Seifritz, 1996, Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe, Neuropsychopharmacology, 14, 253, 10.1016/0893-133X(95)00117-V · DOI
  65. Callaway, 1999, Pharmacokinetics of Hoasca alkaloids in healthy humans, J Ethnopharmacol, 65, 243, 10.1016/S0378-8741(98)00168-8 · DOI · Paper page
  66. Seibert, 2014, Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects, Neuroendocrinology, 100, 17, 10.1159/000364879 · DOI

Cited by

See all 411

Metadata

Authors
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2015-10
Volume
78
Issue
8
Pages
544-553
ISSN
0006-3223 (ISSN-L)
DOI
10.1016/j.biopsych.2014.11.015
OpenAlex
W2109884356
Cited by
411
References
23
FWCI
30.38
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • University Hospital Basel, Switzerland
  • Swiss National Science Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects. https://app.cochat.ai/papers/10.1016/j.biopsych.2014.11.015
The paper
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2015). Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2014.11.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.